Compounds > lercanidipine
Page last updated: 2024-08-24

lercanidipine and Diabetic Glomerulosclerosis

lercanidipine has been researched along with Diabetic Glomerulosclerosis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ceriotti, F; Fedele, D; Lapolla, A; Mosca, A; Paleari, R1
Calls, J; Gómez Campderá, F; Herrera, J; Liébana, A; Manjón, M; Marco, J; Martínez Fernández, J; Méndez, ML; Morey, A; Ocón, J; Pastor, L; Rincón, B; Robles, NR; Rodríguez Martínez, MA; Rodríguez Villareal, I; Tornero, F; Torrijos, J; Villatoro, J1
Crepaldi, G; Dalla Vestra, M; Fioretto, P; Grazioli, V; Lapolla, A; Mosca, A; Pozza, G1

Trials

3 trial(s) available for lercanidipine and Diabetic Glomerulosclerosis

ArticleYear
Biological variability of albumin excretion rate and albumin-to-creatinine ratio in hypertensive type 2 diabetic patients.
    Clinical chemistry and laboratory medicine, 2003, Volume: 41, Issue:9

    Topics: Albuminuria; Calcium Channel Blockers; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dihydropyridines; Humans; Hypertension; Protein Denaturation; Sensitivity and Specificity; Serum Albumin; Temperature

2003
[Lercanidipine in diabetic patients with renal failure].
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2004, Volume: 24, Issue:4

    Topics: Aged; Antihypertensive Agents; Calcium Channel Blockers; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dihydropyridines; Edema; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Proteinuria; Treatment Outcome

2004
Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).
    Diabetes, nutrition & metabolism, 2004, Volume: 17, Issue:5

    Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dihydropyridines; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Ramipril; Treatment Outcome

2004